Clinical Trial Update: Brief Cognitive Behavioral Conjoint Therapy for PTSD With Adjunctive Intranasal Oxytocin [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Brief Cognitive Behavioral Conjoint Therapy for PTSD with adjunctive intranasal oxytocin; study completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder
• Relational Problems

Drugs mentioned

• intranasal oxytocin (oxytocin)

Snippet

Sponsor: San Diego Veterans Healthcare System | Conditions: Post Traumatic Stress Disorder, Relational Problems | Phase 2 | Status: COMPLETED | Results posted: 2023-07-10